Mexico has emerged as a hub/center/destination for regenerative medicine, particularly in the field of stem cell therapies. Numerous/A plethora/Many clinics across the country offer/provide/specialize in a wide range/variety/spectrum of treatments using autologous/allogeneic/donor-derived stem cells. These therapies target/address/treat conditions/

people need to be notified of any stem cell procedure involving minimally manipulated cells not authorized or authorised through the FDA. sufferers and or provider noted end result information needs to be compiled and available for ongoing evaluation of safety and efficacy. The resected tissue is processed and, using a immediate isolation protoco